TRANEXAMIC ACID 100mg. IP

An antifibrinolytic agent that is used widely to prevent and treat hemorrhage. (Natalia Novikova, 2015) Reduces surgical blood loss due to bleeding after trauma and post-partum hemorrhage. (Stanislas Grassin-Delyle, 2019) A beneficial drug in a wide range of hemorrhagic conditions. (C J Dunn, 1999) A promising drug for the prevention and treatment of postpartum hemorrhage after both vaginal and cesarean delivery. (L Sentilhes, 2015) A possible alternative to surgery in menorrhagia, and successfully controls bleeding in pregnancy. (C J Dunn K. L., 1999) Diminishes the menstrual blood loss by 26%–60%. (Hurskainen H. L., 2012) Significantly reduces all-cause mortality and death due to bleeding in trauma patients with significant bleeding. (McCormack, 2012) Significantly improves the quality of life of women with heavy menstrual bleeding. (Hurskainen, 2012) Has the potential to reduce blood loss in gynecological bleeding disorders, such as heavy menstrual bleeding, postpartum hemorrhage, and bleeding irregularities caused by contraceptive implants. (McCormack, 2012) Reduces postoperative blood loss and transfusion requirements in several types of surgery. (C J Dunn, 1999)